基新抗原免疫原性的分子机制
Yury Patskovsky1,2, Aswin Natarajan1,2, Larysa Patskovska1,2
1Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Nature communications
|June 23, 2023
概括
改变的蛋白质酸化会产生癌症声抗原. 一个T细胞受体 (TCR27) 和一种急性髓性白血病基抗原 (pMLL) 之间的特定相互作用揭示了癌症免疫治疗的关键结合机制.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 癌细胞中改变的蛋白质酸化可以产生光新抗原.
- 这些新抗原在癌症免疫性中的确切作用尚未完全理解.
- 了解这些相互作用是开发新型癌症免疫疗法的关键.
研究的目的:
- 阐明一种特定的急性髓性白血病基抗原被T细胞受体识别的机制.
- 为了研究基抗原与T细胞受体之间的相互作用的结构基础.
- 探索这种相互作用对癌症免疫疗法开发的潜力.
主要方法:
- 进行X射线晶体学以确定TCR27和脂-MHC复合物的结构.
- 核磁共振 (NMR) 用于绘制TCR27和MHC-类之间的接口.
- 信息驱动的蛋白质对接生成一个三元复杂模型.
主要成果:
- 该研究确定了一种特定的基抗原,pMLL747-755,被T细胞受体TCR27.7识别.
- 结构和结合分析显示,涉及表位的酸盐组的非共价相互作用对TCR特异性至关重要.
- 对素残留物的修改影响了T细胞激活和TCR-pMHC结合,尽管保持了pMHC的构型和亲和力.
结论:
- 基抗原的酸盐组在TCR27.27的特定识别中起着至关重要的作用.
- 这种对TCR-pMHC相互作用的详细理解可以指导针对癌症免疫治疗的T细胞受体的优化.
- 这些发现支持扩大治疗点和优化T细胞受体,以改善癌症治疗选择.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.5K
09:28Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
11.6K
相关概念视频
Antigens Involved in Adaptive Immunity
563
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
563
Antigen Processing Pathways
1.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.1K
